| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cortical Spreading Depression | 16 | 2017 | 20 | 2.980 |
Why?
|
| Hippocampus | 23 | 2015 | 451 | 2.530 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2021 | 116 | 2.450 |
Why?
|
| Microglia | 12 | 2021 | 123 | 2.110 |
Why?
|
| Exosomes | 5 | 2016 | 60 | 2.000 |
Why?
|
| Oxidative Stress | 8 | 2021 | 467 | 1.990 |
Why?
|
| Neocortex | 6 | 2017 | 98 | 1.680 |
Why?
|
| Rats, Wistar | 24 | 2021 | 300 | 1.460 |
Why?
|
| Astrocytes | 15 | 2021 | 136 | 1.440 |
Why?
|
| Rats | 53 | 2021 | 4028 | 1.440 |
Why?
|
| Myelin Sheath | 5 | 2021 | 66 | 1.390 |
Why?
|
| Migraine Disorders | 3 | 2021 | 41 | 1.300 |
Why?
|
| Trigeminal Ganglion | 2 | 2021 | 14 | 1.290 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2021 | 39 | 1.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2014 | 688 | 1.160 |
Why?
|
| Neurons | 10 | 2021 | 1568 | 1.120 |
Why?
|
| Interferon-gamma | 5 | 2021 | 459 | 1.000 |
Why?
|
| Neuroprotective Agents | 3 | 2017 | 94 | 0.850 |
Why?
|
| Central Nervous System | 2 | 2016 | 139 | 0.820 |
Why?
|
| Animals | 69 | 2021 | 27973 | 0.790 |
Why?
|
| Environment | 2 | 2016 | 230 | 0.780 |
Why?
|
| Evoked Potentials | 5 | 2012 | 193 | 0.720 |
Why?
|
| MicroRNAs | 6 | 2021 | 581 | 0.720 |
Why?
|
| Oligodendroglia | 5 | 2021 | 76 | 0.700 |
Why?
|
| Nitroglycerin | 1 | 2021 | 24 | 0.670 |
Why?
|
| Tissue Culture Techniques | 4 | 2015 | 80 | 0.610 |
Why?
|
| Cytokines | 6 | 2014 | 862 | 0.600 |
Why?
|
| Signal Transduction | 6 | 2014 | 3497 | 0.560 |
Why?
|
| Organ Culture Techniques | 10 | 2013 | 120 | 0.540 |
Why?
|
| Membrane Potentials | 7 | 2014 | 404 | 0.520 |
Why?
|
| Dendritic Cells | 3 | 2021 | 538 | 0.510 |
Why?
|
| Demyelinating Diseases | 2 | 2013 | 48 | 0.500 |
Why?
|
| Brain Ischemia | 8 | 2001 | 407 | 0.460 |
Why?
|
| Cells, Cultured | 10 | 2016 | 2827 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 2021 | 66 | 0.440 |
Why?
|
| Leukocytes | 1 | 2016 | 210 | 0.440 |
Why?
|
| Interleukin-11 | 2 | 2014 | 20 | 0.440 |
Why?
|
| Immunohistochemistry | 14 | 2013 | 1786 | 0.420 |
Why?
|
| Pyramidal Cells | 2 | 2005 | 86 | 0.410 |
Why?
|
| Gliosis | 4 | 2016 | 32 | 0.400 |
Why?
|
| Cold Temperature | 2 | 2010 | 159 | 0.400 |
Why?
|
| Brain | 13 | 2021 | 2337 | 0.390 |
Why?
|
| Interferon-alpha | 1 | 2013 | 187 | 0.390 |
Why?
|
| Immunologic Factors | 1 | 2014 | 175 | 0.370 |
Why?
|
| Biophysical Phenomena | 1 | 2012 | 124 | 0.360 |
Why?
|
| Animals, Newborn | 6 | 2013 | 515 | 0.350 |
Why?
|
| Calcium | 6 | 2004 | 1173 | 0.350 |
Why?
|
| Inflammation | 3 | 2016 | 1049 | 0.350 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 260 | 0.340 |
Why?
|
| Administration, Intranasal | 3 | 2021 | 140 | 0.330 |
Why?
|
| Depression | 1 | 2015 | 540 | 0.330 |
Why?
|
| Models, Immunological | 1 | 2011 | 85 | 0.330 |
Why?
|
| Extracellular Space | 9 | 1994 | 82 | 0.330 |
Why?
|
| Bicarbonates | 6 | 1994 | 58 | 0.330 |
Why?
|
| Microelectrodes | 8 | 2014 | 86 | 0.330 |
Why?
|
| Cerebral Cortex | 7 | 1996 | 569 | 0.320 |
Why?
|
| Hydrogen-Ion Concentration | 17 | 1994 | 479 | 0.320 |
Why?
|
| Models, Neurological | 2 | 2011 | 408 | 0.320 |
Why?
|
| Intracellular Fluid | 5 | 1991 | 32 | 0.310 |
Why?
|
| Electric Stimulation | 7 | 2012 | 344 | 0.300 |
Why?
|
| Trigeminal Caudal Nucleus | 2 | 2003 | 3 | 0.290 |
Why?
|
| Interleukin-1 | 2 | 1999 | 71 | 0.280 |
Why?
|
| Cell Movement | 2 | 2011 | 804 | 0.280 |
Why?
|
| Phosphopyruvate Hydratase | 4 | 2012 | 39 | 0.270 |
Why?
|
| Male | 28 | 2021 | 44355 | 0.270 |
Why?
|
| Endocytosis | 1 | 2008 | 184 | 0.270 |
Why?
|
| Cell Death | 3 | 2011 | 252 | 0.270 |
Why?
|
| Microspheres | 2 | 2004 | 88 | 0.260 |
Why?
|
| In Vitro Techniques | 4 | 2014 | 944 | 0.260 |
Why?
|
| Chloride Channels | 2 | 1998 | 43 | 0.250 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 465 | 0.250 |
Why?
|
| Dinoprostone | 3 | 2008 | 71 | 0.250 |
Why?
|
| Hyperglycemia | 4 | 1997 | 178 | 0.240 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 1996 | 36 | 0.240 |
Why?
|
| Glial Fibrillary Acidic Protein | 4 | 2010 | 55 | 0.230 |
Why?
|
| Myelin Basic Protein | 2 | 2016 | 37 | 0.230 |
Why?
|
| Acid-Base Equilibrium | 5 | 1997 | 31 | 0.230 |
Why?
|
| Potassium Chloride | 4 | 2017 | 75 | 0.210 |
Why?
|
| Rats, Inbred Strains | 13 | 1991 | 300 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2014 | 1236 | 0.210 |
Why?
|
| Axons | 3 | 2016 | 176 | 0.210 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 79 | 0.210 |
Why?
|
| Glutathione | 2 | 2015 | 104 | 0.210 |
Why?
|
| N-Methylaspartate | 4 | 2012 | 45 | 0.210 |
Why?
|
| Potassium | 5 | 1991 | 224 | 0.200 |
Why?
|
| Acidosis | 4 | 2001 | 53 | 0.200 |
Why?
|
| Body Fluids | 3 | 1989 | 35 | 0.200 |
Why?
|
| Neurotoxins | 2 | 2008 | 44 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 367 | 0.200 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 1980 | 0.200 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2004 | 111 | 0.190 |
Why?
|
| Cerebellum | 6 | 1988 | 247 | 0.190 |
Why?
|
| Migraine with Aura | 1 | 2003 | 4 | 0.190 |
Why?
|
| Calcium Signaling | 1 | 2004 | 138 | 0.190 |
Why?
|
| Calcium Channels | 1 | 2004 | 180 | 0.190 |
Why?
|
| Brain Diseases | 2 | 2017 | 172 | 0.190 |
Why?
|
| Lactates | 7 | 1989 | 34 | 0.180 |
Why?
|
| Pregnancy | 4 | 2013 | 3128 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2013 | 40 | 0.180 |
Why?
|
| Minocycline | 2 | 2014 | 14 | 0.180 |
Why?
|
| Synapses | 2 | 2011 | 274 | 0.170 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 194 | 0.170 |
Why?
|
| Carbon Dioxide | 5 | 1994 | 194 | 0.170 |
Why?
|
| Lipopolysaccharides | 3 | 2016 | 300 | 0.170 |
Why?
|
| Antibodies | 2 | 2014 | 346 | 0.170 |
Why?
|
| Electrophysiology | 7 | 2004 | 389 | 0.170 |
Why?
|
| Neuroglia | 3 | 2017 | 77 | 0.160 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 47 | 0.160 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 5 | 0.160 |
Why?
|
| Nerve Net | 1 | 2004 | 394 | 0.160 |
Why?
|
| Stem Cells | 2 | 2013 | 386 | 0.150 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1517 | 0.150 |
Why?
|
| Time Factors | 5 | 2012 | 5380 | 0.150 |
Why?
|
| Analysis of Variance | 2 | 2012 | 883 | 0.150 |
Why?
|
| Receptors, Prostaglandin E | 1 | 1999 | 4 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 4 | 2005 | 378 | 0.140 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 1276 | 0.140 |
Why?
|
| Hydrogen | 3 | 1989 | 53 | 0.140 |
Why?
|
| Action Potentials | 4 | 2012 | 578 | 0.140 |
Why?
|
| Trigeminal Nuclei | 1 | 1998 | 3 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2013 | 1611 | 0.140 |
Why?
|
| 4-Aminopyridine | 1 | 1998 | 33 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2012 | 1908 | 0.140 |
Why?
|
| Potassium Channel Blockers | 1 | 1998 | 59 | 0.140 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 2012 | 43 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2020 | 0.140 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 123 | 0.130 |
Why?
|
| Random Allocation | 1 | 2017 | 308 | 0.130 |
Why?
|
| Lipoxygenase | 1 | 1996 | 9 | 0.130 |
Why?
|
| Nasal Mucosa | 1 | 2017 | 193 | 0.130 |
Why?
|
| Eicosanoids | 1 | 1996 | 17 | 0.120 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 135 | 0.120 |
Why?
|
| Female | 9 | 2021 | 48542 | 0.120 |
Why?
|
| Isoenzymes | 1 | 1996 | 271 | 0.120 |
Why?
|
| Ion Channel Gating | 1 | 1998 | 302 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 281 | 0.110 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 255 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 638 | 0.110 |
Why?
|
| Benzylidene Compounds | 1 | 2014 | 2 | 0.110 |
Why?
|
| Spleen | 1 | 2016 | 372 | 0.110 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2014 | 20 | 0.110 |
Why?
|
| Actins | 1 | 1998 | 467 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 1996 | 281 | 0.110 |
Why?
|
| Aniline Compounds | 1 | 2014 | 59 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 1994 | 109 | 0.100 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 15 | 0.100 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 159 | 0.100 |
Why?
|
| Rats, Inbred WKY | 1 | 2013 | 31 | 0.100 |
Why?
|
| Lysophosphatidylcholines | 1 | 2013 | 17 | 0.100 |
Why?
|
| Housing, Animal | 1 | 2014 | 51 | 0.100 |
Why?
|
| Tissue Fixation | 1 | 2013 | 39 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2013 | 68 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 49 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 2 | 2011 | 229 | 0.090 |
Why?
|
| Quantum Dots | 1 | 2012 | 19 | 0.090 |
Why?
|
| Intracellular Membranes | 2 | 1990 | 112 | 0.090 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2012 | 5 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2016 | 550 | 0.090 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 1991 | 7 | 0.090 |
Why?
|
| Biophysics | 1 | 2012 | 153 | 0.090 |
Why?
|
| Cerebellar Nuclei | 1 | 1991 | 5 | 0.090 |
Why?
|
| Oxidants | 1 | 2012 | 86 | 0.090 |
Why?
|
| Serum | 1 | 2012 | 25 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 164 | 0.090 |
Why?
|
| Neural Pathways | 2 | 2004 | 324 | 0.090 |
Why?
|
| Plant Lectins | 1 | 2011 | 10 | 0.090 |
Why?
|
| Endotoxins | 1 | 2011 | 36 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2016 | 703 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 2011 | 72 | 0.080 |
Why?
|
| Indoles | 1 | 1993 | 298 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2011 | 32 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 2011 | 88 | 0.080 |
Why?
|
| Vasodilation | 1 | 2011 | 91 | 0.080 |
Why?
|
| Muscles | 1 | 1991 | 177 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 19 | 0.080 |
Why?
|
| Cerebral Infarction | 2 | 1991 | 71 | 0.080 |
Why?
|
| Cell Shape | 1 | 2011 | 50 | 0.080 |
Why?
|
| Environmental Exposure | 1 | 2013 | 355 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 1269 | 0.080 |
Why?
|
| Sulfonamides | 1 | 1993 | 331 | 0.080 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 23 | 0.080 |
Why?
|
| Organic Chemicals | 1 | 2010 | 36 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 502 | 0.080 |
Why?
|
| Cell Count | 2 | 2003 | 195 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 421 | 0.070 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Ectodysplasins | 1 | 2008 | 4 | 0.070 |
Why?
|
| Brain Injuries | 1 | 2011 | 139 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 725 | 0.070 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2008 | 28 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2004 | 774 | 0.070 |
Why?
|
| Proteins | 1 | 2014 | 790 | 0.070 |
Why?
|
| Electric Fish | 1 | 1988 | 19 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 88 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 1988 | 75 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 941 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2479 | 0.070 |
Why?
|
| Functional Laterality | 2 | 2003 | 204 | 0.070 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1998 | 17 | 0.060 |
Why?
|
| Ammonia | 1 | 1987 | 34 | 0.060 |
Why?
|
| Indicators and Reagents | 2 | 2001 | 68 | 0.060 |
Why?
|
| Protein Denaturation | 1 | 1987 | 109 | 0.060 |
Why?
|
| Insulin | 1 | 2012 | 1184 | 0.060 |
Why?
|
| Chlorides | 3 | 1994 | 100 | 0.060 |
Why?
|
| Zinc | 2 | 1998 | 97 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2008 | 245 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2011 | 727 | 0.060 |
Why?
|
| Carbonic Acid | 1 | 1986 | 1 | 0.060 |
Why?
|
| Carbonates | 1 | 1986 | 5 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 1998 | 312 | 0.060 |
Why?
|
| Fishes | 3 | 1978 | 143 | 0.060 |
Why?
|
| Glucose | 1 | 2008 | 686 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2005 | 13 | 0.060 |
Why?
|
| Styrenes | 1 | 2005 | 6 | 0.060 |
Why?
|
| Lactic Acid | 4 | 1989 | 93 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 300 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 1987 | 501 | 0.050 |
Why?
|
| Immunoassay | 1 | 2004 | 99 | 0.050 |
Why?
|
| Sodium Acetate | 1 | 2004 | 1 | 0.050 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2004 | 6 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 49 | 0.050 |
Why?
|
| Calcium Channels, P-Type | 1 | 2004 | 8 | 0.050 |
Why?
|
| Dentate Gyrus | 1 | 2004 | 33 | 0.050 |
Why?
|
| Reference Standards | 1 | 2004 | 145 | 0.050 |
Why?
|
| Vasodilator Agents | 2 | 2011 | 132 | 0.050 |
Why?
|
| Lysine | 1 | 2005 | 182 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 118 | 0.050 |
Why?
|
| Hypoxia | 1 | 2008 | 672 | 0.050 |
Why?
|
| Homeostasis | 2 | 2004 | 459 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 83 | 0.050 |
Why?
|
| Reference Values | 1 | 2004 | 603 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2004 | 710 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2004 | 223 | 0.050 |
Why?
|
| Seizures | 1 | 2004 | 312 | 0.040 |
Why?
|
| Cervical Cord | 1 | 2021 | 15 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2021 | 63 | 0.040 |
Why?
|
| Blood Glucose | 1 | 1985 | 866 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 448 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2001 | 141 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2001 | 309 | 0.040 |
Why?
|
| Biological Transport | 2 | 2017 | 398 | 0.040 |
Why?
|
| Buffers | 2 | 1991 | 24 | 0.040 |
Why?
|
| Menstruation-Inducing Agents | 1 | 1999 | 1 | 0.040 |
Why?
|
| Fura-2 | 1 | 1999 | 21 | 0.040 |
Why?
|
| Second Messenger Systems | 1 | 1999 | 39 | 0.040 |
Why?
|
| Sodium | 2 | 1978 | 328 | 0.040 |
Why?
|
| Humans | 3 | 2017 | 93132 | 0.040 |
Why?
|
| Adenylyl Cyclases | 1 | 1999 | 105 | 0.040 |
Why?
|
| Macrophage-1 Antigen | 1 | 1998 | 18 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 1998 | 17 | 0.030 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1998 | 23 | 0.030 |
Why?
|
| Cytochalasin D | 1 | 1998 | 15 | 0.030 |
Why?
|
| Phalloidine | 1 | 1998 | 9 | 0.030 |
Why?
|
| Gelsolin | 1 | 1998 | 11 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1999 | 275 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1998 | 22 | 0.030 |
Why?
|
| Cell Size | 1 | 1998 | 71 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1998 | 142 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 215 | 0.030 |
Why?
|
| Oxygen | 2 | 1993 | 749 | 0.030 |
Why?
|
| Masoprocol | 1 | 1996 | 3 | 0.030 |
Why?
|
| Quinacrine | 1 | 1996 | 10 | 0.030 |
Why?
|
| Phenylephrine | 1 | 1996 | 29 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1996 | 25 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 885 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1996 | 37 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 30 | 0.030 |
Why?
|
| Mitochondria | 1 | 2001 | 612 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 1996 | 35 | 0.030 |
Why?
|
| Indomethacin | 1 | 1996 | 58 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1996 | 36 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1996 | 126 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 1996 | 99 | 0.030 |
Why?
|
| Entorhinal Cortex | 1 | 1995 | 16 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1996 | 311 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1995 | 80 | 0.030 |
Why?
|
| Ion-Selective Electrodes | 1 | 1994 | 5 | 0.030 |
Why?
|
| Amygdala | 1 | 1995 | 86 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 1996 | 360 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1991 | 429 | 0.020 |
Why?
|
| Sumatriptan | 1 | 1993 | 2 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 1993 | 32 | 0.020 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1993 | 14 | 0.020 |
Why?
|
| Genes, fos | 1 | 1993 | 24 | 0.020 |
Why?
|
| Meninges | 1 | 1993 | 13 | 0.020 |
Why?
|
| Microinjections | 1 | 1993 | 67 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1993 | 40 | 0.020 |
Why?
|
| Motor Cortex | 1 | 1995 | 209 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 1993 | 63 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1993 | 83 | 0.020 |
Why?
|
| Luminescence | 1 | 2012 | 20 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1993 | 183 | 0.020 |
Why?
|
| Logistic Models | 1 | 1996 | 1240 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 137 | 0.020 |
Why?
|
| Endosomes | 1 | 2012 | 86 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 1991 | 14 | 0.020 |
Why?
|
| Kinetics | 2 | 1991 | 1463 | 0.020 |
Why?
|
| Capillaries | 1 | 1991 | 83 | 0.020 |
Why?
|
| Electrodes | 1 | 1991 | 97 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1991 | 81 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 89 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 191 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1991 | 291 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2011 | 239 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 174 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1991 | 124 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 400 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 303 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 163 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 1991 | 109 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 371 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 1991 | 114 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 1990 | 34 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 200 | 0.020 |
Why?
|
| Beverages | 1 | 1969 | 16 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 280 | 0.020 |
Why?
|
| Cell Survival | 2 | 2008 | 1002 | 0.020 |
Why?
|
| Barium | 1 | 1989 | 32 | 0.020 |
Why?
|
| Cell Division | 1 | 1990 | 689 | 0.020 |
Why?
|
| Rest | 1 | 1989 | 50 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 653 | 0.020 |
Why?
|
| Gene Expression | 1 | 1993 | 1304 | 0.020 |
Why?
|
| Cinnamates | 1 | 2008 | 8 | 0.020 |
Why?
|
| Caffeine | 1 | 1969 | 85 | 0.020 |
Why?
|
| Thiourea | 1 | 2008 | 10 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2008 | 31 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 1991 | 418 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2008 | 124 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 1990 | 506 | 0.020 |
Why?
|
| Cholesterol | 1 | 1969 | 364 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 178 | 0.020 |
Why?
|
| Immunity | 1 | 2008 | 153 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 887 | 0.020 |
Why?
|
| Protons | 1 | 1987 | 100 | 0.020 |
Why?
|
| Partial Pressure | 1 | 1986 | 46 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1986 | 166 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 1129 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 409 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 3450 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1732 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 1719 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1985 | 287 | 0.010 |
Why?
|
| United States | 1 | 2017 | 7581 | 0.010 |
Why?
|
| Glioma | 1 | 1986 | 298 | 0.010 |
Why?
|
| Acetazolamide | 1 | 1983 | 10 | 0.010 |
Why?
|
| Manganese | 1 | 1983 | 55 | 0.010 |
Why?
|
| Mammals | 1 | 1985 | 259 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 2545 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 3431 | 0.010 |
Why?
|
| Ischemia | 1 | 1983 | 252 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1986 | 810 | 0.010 |
Why?
|
| Models, Biological | 1 | 1986 | 1768 | 0.010 |
Why?
|
| Sucrose | 2 | 1991 | 63 | 0.010 |
Why?
|
| Electrolytes | 1 | 1978 | 52 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1978 | 121 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 1976 | 12 | 0.010 |
Why?
|
| Monensin | 1 | 1976 | 16 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 12230 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1991 | 33 | 0.010 |
Why?
|
| Body Water | 1 | 1991 | 34 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1991 | 81 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1969 | 5 | 0.000 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 1969 | 8 | 0.000 |
Why?
|
| Cholelithiasis | 1 | 1969 | 36 | 0.000 |
Why?
|
| Tea | 1 | 1969 | 19 | 0.000 |
Why?
|
| Hydrochloric Acid | 1 | 1989 | 10 | 0.000 |
Why?
|
| Solutions | 1 | 1987 | 83 | 0.000 |
Why?
|
| Injections | 1 | 1987 | 121 | 0.000 |
Why?
|
| Necrosis | 1 | 1987 | 203 | 0.000 |
Why?
|
| Capillary Permeability | 1 | 1987 | 131 | 0.000 |
Why?
|
| Dimethadione | 1 | 1986 | 1 | 0.000 |
Why?
|
| Autoradiography | 1 | 1986 | 50 | 0.000 |
Why?
|
| Rats, Inbred F344 | 1 | 1986 | 160 | 0.000 |
Why?
|
| Cats | 1 | 1978 | 281 | 0.000 |
Why?
|